RXO enters the week after earnings season with the loudest analyst activity in months, yet the short side is quietly adding pressure at the same time — a split picture that makes the setup ahead of its August 5 print genuinely interesting.
The Street has turned noticeably more constructive in the past week. BMO Capital initiated coverage with an Outperform and a $35 target — the most bullish call on the name right now. Truist lifted its target from $26 to $30 while keeping a Buy. Stifel did the same, raising from $22 to $30. Even Citigroup, sitting on a Neutral, moved its target up to $30 from $24. The lone holdout is Susquehanna, which raised its target slightly to $20 but kept a Negative rating. Thirteen analysts hold a Hold consensus, and the mean target clusters around the low-to-mid $30s — above the current $28.04 close but not wildly so. The bull case rests on margin recovery and the Coyote acquisition expanding the carrier network. The bear case is harder to dismiss: pro forma truckload volumes fell 8% year-over-year in the most recent quarter, automotive freight remains weak, and EPS estimates have been revised down materially. Factor scores tell a similar story — EPS momentum over 30 and 90 days ranks in the 94th and 99th percentiles respectively, reflecting the direction of analyst revisions rather than the level. Short score and days-to-cover both sit near the bottom of the universe, flags worth noting alongside the bullish narrative.
Short positioning cuts against the upbeat analyst tone. Short interest has climbed roughly 19% over the past 30 days to 9.1% of the free float — a meaningful level for a mid-cap freight broker. The week-on-week rise of 5.6% puts shorts at their most extended in recent months, even as the stock added 4.4% on the week to $28.04. Borrowing the stock remains cheap, with cost to borrow at just 0.41% and falling — down 12% on the week and 17% over the past month. Availability is genuinely loose at 340%, meaning roughly three and a half shares are available to borrow for every one already lent out, well above the 52-week low of 194%. There is no squeeze pressure here. The combination of rising short interest and ample, cheap borrow suggests shorts are adding deliberately rather than under any cost or availability constraint.
Options positioning adds another layer of caution. The put/call ratio jumped to 2.51 on July 14 — nearly three standard deviations above its 20-day mean of 1.39. That reading is the highest in recent months, outside of a single spike on June 30. A PCR running that far above its own norm points to heavier demand for downside protection, which sits in tension with the wave of analyst upgrades filed this same week. Whether this is hedging by holders or outright bearish positioning is unclear, but the scale of the deviation is notable.
The institutional base is unusually concentrated. Orbis Investment Management holds 22% of shares, MFN Partners 17%, and BlackRock another 15%. With roughly 55% of the float held by three names, thin liquidity could amplify moves in either direction around the August 5 earnings date. The last earnings print saw the stock jump over 10% on the day before giving back most of those gains over the following week — a pattern that rewards getting the direction right but punishes holding through the fade.
With August 5 approaching, the key tension is whether the volume trajectory is stabilising fast enough to justify the multiple re-rating the analyst community has started pricing in — or whether the shorts building at 9% of float see something the upgraded targets do not.
See the live data behind this article on ORTEX.
Open RXO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
